GeoVax Labs, Inc. (76) | License Agreements (4)
Recent Contracts
-
Exclusive License Agreement, dated November 9, 2021, by and between GeoVax, Inc. and City of Hope
(Filed With SEC on November 10, 2021)
-
Assignment and License Agreement, dated September 28, 2021, by and between GeoVax, Inc. and PNP Therapeutics, Inc
(Filed With SEC on September 29, 2021)
-
Patent and Biological Materials License Agreement for Internal Research Use with the National Institute of Allergy and Infectious Diseases, dated November 25, 2020
(Filed With SEC on November 30, 2020)
-
Patent and Biological Materials License Agreement with the National Institute of Allergy and Infectious Diseases, dated October 22, 2020
(Filed With SEC on October 26, 2020)
